Historical ce News Stories
Celanese Raises Prices; CE Stock Hits 52-Week High
Celanese announced targeted price increases across engineered materials (effective May 1) and acetyl products (mid‑March), driving margin defense and contributing to a recent 52‑week high and insider buying. Investors should watch Q1 results and margin flow-through as the company pursues deleveraging and integration gains from prior acquisitions.
Celanese Cuts Debt Cost, Lifts Acetyls Prices Now
Celanese (CE) recently completed a debt-refinancing to extend maturities and lower borrowing costs while announcing March price increases across its acetyls portfolio. These moves should support margins and liquidity ahead of the company's May 6 Q1 earnings call.
Celanese: Board Exit, Micromax Sale Fuels CE Rally
Recent concrete developments at Celanese (CE) — a board resignation, the Micromax divestiture, a large impairment charge, and improving technical and cash-flow signals — have combined to reshape near-term investor expectations and create a clearer path toward deleveraging and potential upside.
Celanese Sells Micromax; Targets Debt, Cuts Costs.
Celanese completed the Micromax divestiture, boosting liquidity for debt reduction while reporting softer volumes in acetyl and engineered materials. Cost cuts, plant closure plans and a $700–$800M free cash flow target shape near-term CE stock outlook.
Celanese $500M Micromax Deal Boosts Deleveraging!!
Celanese completed the sale of its Micromax business for roughly $500 million, a concrete step toward reducing its elevated leverage. Despite the cash infusion, shares slipped on Feb. 23 as investors remained cautious; lower trading volume and broader weakness left CE underperforming peers. The divestiture improves near-term liquidity and should be monitored for its impact on debt paydown, interest coverage and free cash flow.
Celanese Debt Cuts and FCF Surge Fuel CE Rally Now
Celanese’s latest quarter showed a sharp operating recovery but missed EPS and revenue expectations. Concrete actions — $4B debt refinancing, $773M FY free cash flow, planned asset sales, and targeted cost and working-capital reductions — strengthen liquidity and drive near-term investor focus. Improved technical indicators add a possible upside catalyst if execution continues.
Celanese Price Hikes and $0.03 Dividend Signal Now
Celanese (NYSE: CE) announced a $0.03 quarterly dividend and targeted price increases of $50–$100/MT across key acetate and ester product lines in the Americas. Those concrete moves aim to offset elevated feedstock costs and shore up margins as specialty-chemical peers face persistent EBITDA pressure and rising leverage. The actions are a clear signal of pricing power and capital-allocation discipline for S&P 500-listed Celanese.
Chemours Surges After RS Upgrade; Earnings Set Now
Chemours (CC) recently hit an RS Rating of 83 and broke above a 16.58 handle, sparking a >5% move. With Q4 2025 results scheduled for Feb 19–20, 2026 and recent weak fundamentals, investors face a tension between technical momentum and operational headwinds.